103 related articles for article (PubMed ID: 8862727)
21. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
Hughes CS; Irvin CG; Rockwell S
Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
[TBL] [Abstract][Full Text] [Related]
22. Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Dirix L; Catimel G; Koier I; Provè A; Schrijvers D; Joossens E; De Bruijn E; Ardiet C; Evene E; Dumortier A
Anticancer Drugs; 1995 Feb; 6(1):53-63. PubMed ID: 7756684
[TBL] [Abstract][Full Text] [Related]
23. KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activation.
McAdam SR; Knox RJ; Hartley JA; Masters JR
Biochem Pharmacol; 1998 Jun; 55(11):1777-83. PubMed ID: 9714295
[TBL] [Abstract][Full Text] [Related]
24. The cytotoxicity of mitomycin C and adriamycin in genetically engineered V79 cell lines and freshly isolated rat hepatocytes.
Goeptar AR; te Koppele JM; Glatt HR; Groot EJ; Seidel A; Barrenscheen M; Wölfel C; Doehmer J; Vermeulen NP
Chem Biol Interact; 1995 Jul; 97(2):149-68. PubMed ID: 7606813
[TBL] [Abstract][Full Text] [Related]
25. Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in mice.
Ashizawa T; Okabe M; Gomi K; Hirata T
Anticancer Drugs; 1993 Apr; 4(2):181-8. PubMed ID: 8490196
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia.
Ludwig CU; Peng YM; Beaudry JN; Salmon SE
Cancer Chemother Pharmacol; 1984; 12(3):146-50. PubMed ID: 6423304
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
Kim SY; Rockwell S
Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
Rockwell S; Kim SY
Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
[TBL] [Abstract][Full Text] [Related]
29. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant.
Marshall RS; Rauth AM
Cancer Res; 1986 Jun; 46(6):2709-13. PubMed ID: 3084075
[TBL] [Abstract][Full Text] [Related]
30. Chemopotentiation of mitomycin C cytotoxicity in vitro by platinum complexes.
Teicher BA; Gunner LJ; Roach JA
Br J Cancer; 1985 Dec; 52(6):833-9. PubMed ID: 3935149
[TBL] [Abstract][Full Text] [Related]
31. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
Marshall RS; Rauth AM
Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
[TBL] [Abstract][Full Text] [Related]
32. Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster ovary cells overexpressing DT-diaphorase.
Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
Biochem Pharmacol; 1996 Jun; 51(12):1669-78. PubMed ID: 8687482
[TBL] [Abstract][Full Text] [Related]
33. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.
Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):456-60. PubMed ID: 8552660
[TBL] [Abstract][Full Text] [Related]
34. Induction of protein-DNA complexes in HeLa S3 cells by KW-2149, a new derivative of mitomycin C.
Fujii N; Arai H; Saito H; Kasai M; Nakano H
Cancer Res; 1993 Oct; 53(19):4466-8. PubMed ID: 8402614
[TBL] [Abstract][Full Text] [Related]
35. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
[TBL] [Abstract][Full Text] [Related]
36. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
Dulhanty AM; Whitmore GF
Cancer Res; 1991 Apr; 51(7):1860-5. PubMed ID: 1900739
[TBL] [Abstract][Full Text] [Related]
37. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A
Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602
[TBL] [Abstract][Full Text] [Related]
38. Redox generation of nitric oxide to radiosensitize hypoxic cells.
Mitchell JB; DeGraff W; Kim S; Cook JA; Gamson J; Christodoulou D; Feelisch M; Wink DA
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):795-8. PubMed ID: 9845098
[TBL] [Abstract][Full Text] [Related]
39. Sarcoma-180 cells and human colorectal tumor cells under in vitro hypoxic conditions are more sensitive to mitomycin C and carboquone.
Kusumoto T; Maehara Y; Sakaguchi Y; Kohnoe S; Emi Y; Sugimachi K
Eur J Surg Oncol; 1991 Aug; 17(4):358-63. PubMed ID: 1908390
[TBL] [Abstract][Full Text] [Related]
40. Role of dt-diaphorase as a determinant of sensitivity to mitomycin analogs in nonsmall cell lung-cancer cell-lines.
Bando T; Kasahara K; Shibata K; Nakatsumi Y; Fujimura M; Matsuda T
Int J Oncol; 1994 Oct; 5(4):819-25. PubMed ID: 21559647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
